Alan M Garber has sold EXEL and made no open-market buys since Dec 2016

Alan M. Garber, M.D., Ph.D., is an American physician, health economist, and academic leader who serves as a director of Exelixis, Inc. (EXEL) and has recently traded Exelixis stock in his capacity as a corporate insider.( He was first appointed to the Exelixis board of directors in 2004, bringing expertise in medicine, economics, and health policy to the company’s governance.( In addition to his Exelixis role, Garber has served on the board of Vertex Pharmaceuticals Inc. and has accumulated significant equity holdings and trading activity in these biotechnology companies as reported in SEC filings.(

Professionally, Garber is the president of Harvard University and Mallinckrodt Professor of Health Care Policy at Harvard Medical School, as well as a professor of economics, public policy, and health policy across multiple Harvard faculties.( Before joining Harvard, he held prominent faculty positions at Stanford University, including Professor of Medicine, Economics, and Health Research and Policy, and founded Stanford’s Center for Health Policy and the Center for Primary Care and Outcomes Research.( He earned his A.B. in Economics summa cum laude from Harvard College, followed by a master’s and Ph.D. in Economics from Harvard and an M.D. from Stanford, establishing a career at the intersection of clinical medicine, economics, and health care policy.(

Written by Perplexity from public sources.